The most important thing to keep in mind when you look at Walgreens today is -- unfortunately-- its weak business performance ...

Walgreens' stock price isn't going anywhere fast. Walgreens' weak business performance is not a new phenomenon. It has been struggling for years. At first, it was more about sluggish growth.

Walgreens Boots Alliance's fiscal third-quarter results came in above FactSet consensus estimates. Total revenue of $39 billion was up 7.2% year over year, and adjusted earnings per share declined ...

WBA’s Q3 Sales. Walgreens Boots recorded total sales of $38.99 billion in the fiscal third quarter, up 7.2% year over year and 6.9% at CER. The top line also surpassed the Zacks Consensus ...

The stock rose 0.6% in premarket trading. U.S. retail pharmacy sales were $30.72 billion, up from $28.5 billion in the prior year's quarter, to mark the ninth straight quarter of year-over-year ...

On this episode of Stock Movers: - Walgreens (WBA) shares rise after the company reported quarterly profit that beat Wall Street’s expectations. It's a hopeful sign as the pharmacy giant ...

In the latest market close, Walgreens Boots Alliance (WBA) reached $11.20, with a -0.44% movement compared to the previous day. The stock fell short of the S&P 500, which registered a gain of 0.41 ...

Walgreens Boots Alliance (NASDAQ: WBA) is one of the largest pharmacy retailers in the United States. While there's a potential turnaround opportunity for the business in the years ahead, that ...

Walgreens Boots Alliance continues to see weakness in U.S. front-end sales, says Chief Executive Tim Wentworth Last Updated: June 26, 2025 at 8:57 a.m. ET First Published: June 26, 2025 at 7:14 a ...